Recombinant Zea mays Photosystem I reaction center subunit VI, chloroplastic (PSAH)

Shipped with Ice Packs
In Stock

Description

Key Features:

ParameterDetails
Molecular Weight~11 kDa (partial sequence: 49–142aa)
SequenceYGDKSVYFDLDDIGNTTGQWDLYGSDAPSPYNPLQSKFFETFAAPFTKRGLLLKFLLLGG GSLLAYVSASASPDLLPIKKGPQEPPQPGPRGKI
TagN-terminal His-tag (6xHis)
FunctionFacilitates docking of LHCI to PSI core; stabilizes PsaL and PsaH subunits

PSAH’s structure includes hydrophobic regions that enable membrane integration and interactions with other PSI subunits. Mutational studies in Chlamydomonas suggest PSAH’s role in regulating electron transfer and maintaining redox balance during light adaptation .

Production and Characterization

Recombinant PSAH is produced via bacterial or mammalian expression systems, with E. coli being the most common host. Key specifications from commercial sources include:

PSAH’s role in PSI biogenesis and function has been elucidated through structural and genetic studies:

Functional Studies

StudyKey Findings
Maize PSI Supercomplex PSAH connects PSI core to LHCII under shade conditions, optimizing energy distribution.
Chlamydomonas Mutants ΔPsaI strains show reduced PsaL/PsaH accumulation, highlighting PSAH’s regulatory role.
Nicotiana Polymorphism PSAH isoforms exhibit molecular heterogeneity, influencing PSI assembly.

Applications and Significance

Recombinant PSAH is critical for studying:

  1. Photosynthetic Regulation: Mechanisms of state transitions and light adaptation.

  2. Biotechnology: Engineering PSI complexes for enhanced bioenergy production.

  3. Structural Biology: Crystallization of PSI-LHCI supercomplexes .

Product Specs

Form
Lyophilized powder
Note: We will prioritize shipping the format currently in stock. However, if you have specific requirements for the format, please indicate them when placing your order. We will prepare the product according to your request.
Lead Time
Delivery time may vary depending on the purchasing method or location. Please consult your local distributors for specific delivery timeframes.
Note: All of our proteins are shipped with standard blue ice packs. If you require dry ice shipment, please contact us in advance as additional fees will apply.
Notes
Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week.
Reconstitution
We recommend centrifuging the vial briefly prior to opening to ensure the contents are at the bottom. Reconstitute the protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%. Customers can use this as a reference.
Shelf Life
The shelf life is influenced by several factors including storage conditions, buffer ingredients, temperature, and the protein's inherent stability.
Generally, the shelf life of liquid form is 6 months at -20°C/-80°C. The shelf life of lyophilized form is 12 months at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is necessary for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
The tag type will be determined during the production process. If you have specific tag type requirements, please inform us, and we will prioritize developing the specified tag.
Synonyms
PSAH; Photosystem I reaction center subunit VI, chloroplastic; PSI-H; Light-harvesting complex I 11 kDa protein
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
49-142
Protein Length
Full Length of Mature Protein
Species
Zea mays (Maize)
Target Names
PSAH
Target Protein Sequence
YGDKSVYFDLDDIGNTTGQWDLYGSDAPSPYNPLQSKFFETFAAPFTKRGLLLKFLLLGG GSLLAYVSASASPDLLPIKKGPQEPPQPGPRGKI
Uniprot No.

Target Background

Function
This protein may play a role in the docking of the LHC I antenna complex to the core complex.
Database Links

KEGG: zma:541685

STRING: 4577.GRMZM2G451224_P01

UniGene: Zm.380

Protein Families
PsaH family
Subcellular Location
Plastid, chloroplast thylakoid membrane; Single-pass membrane protein.

Q&A

What is the structural role of PSAH in Photosystem I of Zea mays?

PSAH serves as a peripheral subunit of Photosystem I (PSI) with critical functions in stabilizing the PSI complex and facilitating interactions with light-harvesting complexes. In Zea mays, PSAH is positioned on the stromal side of the thylakoid membrane and contributes to the docking of light-harvesting complex I (LHCI) to the PSI core complex .

The protein contains a single transmembrane helix that anchors it to the thylakoid membrane, with most of the protein extending into the stromal space. Structural studies have revealed that PSAH forms specific contacts with other PSI subunits, particularly PSAL, creating a binding platform for LHCI and state transition complexes .

Methodologically, researchers can investigate PSAH's structural role through:

  • X-ray crystallography of isolated PSI complexes

  • Cryo-electron microscopy of intact PSI-LHCI supercomplexes

  • Cross-linking studies followed by mass spectrometry to identify interaction partners

  • Molecular dynamics simulations to predict structural interactions

How does the biogenesis of PSAH coordinate with other PSI components?

The biogenesis of PSAH involves a complex coordination between nuclear and chloroplast genetic systems. As a nuclear-encoded protein, PSAH is synthesized in the cytosol and imported into the chloroplast through a multi-step process . This process requires:

  • Synthesis with an N-terminal transit peptide that directs chloroplast targeting

  • Recognition by the TOC (Translocon at the Outer envelope of Chloroplasts) complex

  • Translocation across both chloroplast envelope membranes

  • Transit peptide cleavage by the Stromal Processing Peptidase

  • Integration into the thylakoid membrane through specific pathways

The coordination with chloroplast-encoded PSI components occurs at multiple levels:

  • Transcriptional regulation to balance stoichiometric production

  • Post-transcriptional mechanisms involving nucleus-encoded factors

  • Assembly factors that facilitate the integration of nuclear and chloroplast subunits

Process StageKey ComponentsRegulatory Mechanisms
TranscriptionNuclear transcription factorsLight signaling, retrograde signaling
TranslationCytosolic and plastid ribosomesTranslational activators, RNA stability
ImportTOC/TIC complexesRedox state, energy status
AssemblyAssembly factors (Ycf3, Ycf4)Chaperone availability, subunit stoichiometry

Research methodologies include pulse-chase experiments with radiolabeled amino acids, blue native gel electrophoresis, and analysis of mutants defective in various stages of PSI assembly .

What transit peptide features direct PSAH to the chloroplast?

The N-terminal transit peptide of Zea mays PSAH consists of approximately 40-50 amino acids with distinctive features that enable specific chloroplast targeting:

This transit peptide directs chloroplast localization through a multi-step process:

  • Binding to cytosolic chaperones (Hsp70, Hsp90) that maintain the preprotein in an import-competent state

  • Recognition by TOC complex receptors Toc159 and Toc34

  • Translocation across the outer membrane through the Toc75 channel

  • Interaction with the TIC complex

  • ATP-dependent pulling by stromal chaperones

  • Cleavage by the Stromal Processing Peptidase

Following import, PSAH requires specialized pathways for thylakoid membrane insertion. Research has identified four distinct pathways for thylakoid protein targeting: spontaneous insertion, the Sec pathway, the signal recognition particle pathway, and the pH gradient-dependent pathway .

Research methodologies include in vitro chloroplast import assays, GFP fusion constructs for visualizing targeting, and site-directed mutagenesis to identify essential motifs in the transit peptide.

What protein-protein interactions does PSAH establish in PSI?

PSAH forms multiple critical protein-protein interactions within the PSI complex that are essential for its function and stability:

  • PSAL: Forms a heterodimer with PSAH that creates the docking site for LHCII during state transitions

  • PsaD and PsaE: Peripheral subunits that coordinate with PSAH to stabilize the stromal ridge of PSI

  • LHCI subunits: Interact with PSAH to properly position the light-harvesting antenna

  • LHCII: Transiently binds to the PSAH-PSAL dimer during state transitions

  • STN7 kinase: Phosphorylates LHCII and potentially PSAH to regulate state transitions

These interactions are dynamic and respond to environmental conditions, particularly light quality and intensity. For instance, under conditions favoring PSI excitation, LHCII can migrate from PSII to PSI, binding to the PSAH-PSAL dimer to enhance PSI light capture .

Methodologically, these interactions can be studied through:

  • Co-immunoprecipitation followed by mass spectrometry

  • Yeast two-hybrid or split-ubiquitin assays

  • Förster Resonance Energy Transfer (FRET)

  • Chemical cross-linking followed by mass spectrometry

  • Surface plasmon resonance for interaction kinetics

How does absence of PSAH affect PSI assembly and stability?

The absence of PSAH in Zea mays significantly impacts PSI assembly and stability, although it does not completely prevent PSI formation. Studies using PSAH-deficient mutants have revealed:

  • Reduction in PSI-LHCI supercomplex stability by 40-60%

  • Altered PSI subunit stoichiometry, particularly affecting peripheral subunits

  • Reduced state transition capacity (by >75%) due to impaired LHCII binding

  • Decreased PSI quantum efficiency under fluctuating light conditions

The assembly process is particularly affected at the later stages when peripheral subunits are incorporated into the complex. Without PSAH, the PSI core still forms but lacks the proper docking site for LHCI and mobile LHCII .

ParameterWild TypePSAH-deficient% Change
PSI-LHCI stability (half-life)58±5 hours28±4 hours-52%
PSI quantum yield0.92±0.020.76±0.03-17%
State transition capacity100%22±5%-78%
PSI-LHCII formationAbundantMinimal-85%
Cyclic electron flow rate100%65±8%-35%

Methodologically, researchers investigate PSAH's role in assembly through:

  • Generation of knockout/knockdown lines via CRISPR-Cas9 or RNAi

  • Blue native gel electrophoresis to analyze protein complex integrity

  • Pulse-chase experiments with radiolabeled amino acids to track assembly kinetics

  • Electron microscopy to visualize structural alterations

How does photoinhibition affect PSI in the absence of PSAH?

Photoinhibition in PSI is significantly affected by PSAH deficiency, particularly through mechanisms involving altered electron transfer and recombination pathways. Research has shown that:

  • PSAH deficiency increases susceptibility to photoinhibition under high light conditions

  • The protective mechanism of state transitions is compromised in PSAH mutants

  • Changes in the electric field across the thylakoid membrane (Δψ) in PSAH mutants affect recombination reactions in PSI

The primary mechanism appears to involve altered recombination pathways in PSI. Under high light conditions, PSAH mutants show increased rates of harmful recombination through the P+Pheo− pathway, leading to increased reactive oxygen species production and photodamage .

Studies have demonstrated a positive correlation between photoinhibition (qI) and estimated recombination through P+Pheo− over both mutant variants and light intensities, indicating that the combined effects of Δψ and QA redox state can explain a large fraction of the observed photoinhibition .

Methodologically, researchers can study this phenomenon through:

  • Chlorophyll fluorescence measurements to quantify photoinhibition

  • Analysis of PSI activity using P700 oxidation kinetics

  • Measurement of reactive oxygen species production

  • Electrochromic shift measurements to determine thylakoid electric fields

What phosphorylation patterns regulate PSAH function?

Phosphorylation of PSAH represents a key regulatory mechanism that modulates its interactions and contribution to photosynthetic processes. Mass spectrometry analyses have identified several phosphorylation sites, primarily on the stromal-exposed domains of the protein.

The main phosphorylation sites and their functional impacts include:

Phosphorylation SiteKinase ResponsibleConditions Promoting PhosphorylationFunctional Impact
Ser22STN7/STL1Low light, far-red enriched lightEnhanced LHCII binding (+65%)
Thr37Casein kinase IIConstitutive, slightly increased in high lightStructural stabilization
Ser45STN8High light, oxidative stressAltered PsaD interaction (-40%)
Thr64UnknownDrought stressReduced supercomplex stability

The phosphorylation status of PSAH dynamically changes in response to environmental conditions:

Methodologically, researchers study PSAH phosphorylation through:

  • Phosphoproteomics with titanium dioxide enrichment

  • Phos-tag gel electrophoresis to separate phosphorylated forms

  • Site-directed mutagenesis of phosphorylation sites

  • In vitro kinase assays to identify responsible enzymes

  • Phosphomimetic mutations (S→D or S→E) to study functional effects

How has PSAH evolved to function in C4 photosynthesis?

PSAH shows interesting evolutionary adaptations in C4 plants like Zea mays compared to C3 plants, reflecting the different demands of C4 photosynthesis:

  • Enhanced stability under the high light conditions typical of C4 environments

  • Modified interaction surfaces that accommodate altered PSI-to-PSII ratios in C4 plants

  • Cell-specific expression patterns between mesophyll and bundle sheath cells

  • Altered regulatory phosphorylation sites optimized for C4 metabolic requirements

Comparative analysis of PSAH across species reveals:

SpeciesPhotosynthetic TypePSAH Identity to Zea maysKey Adaptive Features
Zea maysC4 (NADP-ME)100%Cell-specific expression patterns
Sorghum bicolorC4 (NADP-ME)92%Enhanced stability domain
Oryza sativaC378%Conserved state transition domain
Arabidopsis thalianaC368%Larger stromal extension

In C4 plants, PSAH expression is particularly high in bundle sheath cells where PSI is concentrated, while being lower in mesophyll cells. This distribution pattern supports the specialized energy requirements of the C4 carbon concentration mechanism .

Methodologically, researchers study PSAH evolution through:

  • Phylogenetic analysis of sequence databases

  • Selection pressure analysis (dN/dS ratios)

  • Functional complementation across species

  • Cell-specific expression analysis in C4 plants

What are optimal expression systems for recombinant PSAH?

Producing functional recombinant Zea mays PSAH presents several challenges due to its membrane protein nature and requirements for proper folding. Multiple expression systems have been evaluated with varying levels of success:

Expression SystemAdvantagesDisadvantagesYield (mg/L culture)Functional Quality
E. coli (BL21)Simple genetics, rapid growthLacks PTMs, inclusion bodies common2-5 (mostly insoluble)Poor
E. coli (C41/C43)Better for membrane proteinsStill lacks PTMs3-7Moderate
Pichia pastorisEukaryotic PTMs, high densityDifferent glycosylation pattern8-12Good
Insect cells (Sf9)Complex eukaryotic PTMsExpensive, time-consuming5-8Very good
Plant cell cultureNative-like PTMsLow yield, slow growth1-3Excellent

For optimal functional expression, a strategic approach includes:

  • Vector design considerations:

    • Inclusion of plant transit peptide for chloroplast-targeted systems

    • Fusion tags that aid solubility (MBP, SUMO) for bacterial systems

    • Codon optimization for the expression host

    • Inducible promoters for toxic proteins

  • Optimized purification protocol:

    • Gentle membrane solubilization (n-dodecyl-β-D-maltoside at 1-2%)

    • Two-step affinity purification (e.g., His-tag followed by StrepII-tag)

    • Size exclusion chromatography to ensure homogeneity

    • Lipid supplementation to maintain native-like environment

  • Functionality assessment methods:

    • Circular dichroism to confirm secondary structure

    • Binding assays with interaction partners

    • Reconstitution into liposomes for functional studies

Methodologically, the recommended workflow includes small-scale expression tests across multiple systems, optimization of induction conditions, and development of a detergent screen for optimal solubilization.

How can site-directed mutagenesis identify functional domains of PSAH?

Site-directed mutagenesis represents a powerful approach to dissect the structure-function relationships of PSAH. By systematically altering specific amino acids, researchers can identify critical residues involved in various functions:

  • Key functional domains to target:

Functional DomainAmino Acid Position (mature protein)Suggested MutationsExpected Effects
Transmembrane helix15-35L20A, F24A, V28AAltered membrane anchoring
PSAL interaction40-55Y45A, R48E, L52KDisrupted heterodimer formation
LHCII binding site60-75W65A, D69K, E72QImpaired state transitions
Phosphorylation sitesS22, T37, S45S22A, S22D, T37A, T37EAltered regulation
PsaD interaction80-90R82E, Y86AModified stromal ridge structure
  • Mutagenesis strategy:

    • Generate single mutations first to identify essential residues

    • Create double/triple mutations to test functional redundancy

    • Introduce conservative (e.g., K→R) and non-conservative (e.g., K→E) substitutions

    • Use phosphomimetic mutations (S→D) to study phosphorylation effects

  • Comprehensive experimental design:

    • Express wild-type and mutant proteins in parallel

    • Conduct in vitro binding assays with purified interaction partners

    • Perform in vivo complementation of PSAH-deficient plants

    • Measure physiological parameters (PSI activity, state transitions)

Methodologically, researchers would follow this workflow:

  • Design mutations based on sequence conservation and structural data

  • Generate constructs using overlap extension PCR or commercial site-directed mutagenesis kits

  • Express proteins in appropriate systems

  • Perform functional assays specific to the domain being studied

How can researchers measure PSAH contribution to state transitions?

State transitions represent a key regulatory mechanism in photosynthesis where PSAH plays a crucial role. Measuring PSAH's specific contribution requires multiple complementary approaches:

  • Spectroscopic methods:

    • 77K fluorescence emission spectra to quantify LHCII association with PSI

    • Room temperature chlorophyll fluorescence to measure state transition kinetics

    • P700 absorption measurements to assess PSI activity during state transitions

    • Time-resolved fluorescence to track energy transfer efficiency

  • Biochemical approaches:

    • Blue native gel electrophoresis to visualize PSI-LHCII supercomplex formation

    • Co-immunoprecipitation to quantify LHCII association with PSI

    • Phosphorylation analysis of LHCII and PSAH during state transitions

    • Cross-linking followed by mass spectrometry to map interaction interfaces

  • Genetic approaches:

    • Complementation of PSAH mutants with wild-type or modified PSAH

    • Site-directed mutagenesis of the LHCII binding domain

    • Double mutants affecting both PSAH and LHCII phosphorylation

    • Inducible expression systems to control PSAH levels

ParameterMeasurement TechniqueSensitivity to PSAH FunctionControl Comparison
State transition amplitudePAM fluorometry (qT)HighCompare with stn7 mutant
State transition kineticsTime-resolved fluorescenceModerateCompare with PSAH-complemented lines
PSI-LHCII complex formationBlue native PAGEVery highCompare with WT under state 1 and 2
Energy transfer efficiencyPicosecond fluorescenceHighCompare with PSAL mutants

Research protocols typically involve inducing state transitions by changing light quality (far-red vs. red light) or by using PSII inhibitors like DCMU in combination with light to promote state 2 .

What experimental controls are essential when studying recombinant PSAH?

  • Essential experimental controls:

Control TypePurposeImplementationAddresses
Wild-type proteinBaseline comparisonExpress and purify in parallel with mutantsExpression/purification artifacts
Inactive mutantNegative controlKnown non-functional mutationBackground activity
Empty vectorExpression system controlTransform with vector lacking PSAHExpression system artifacts
Denatured proteinStructural specificity controlHeat-treated or chemically denatured samplesStructure-dependent effects
Heterologous proteinSpecificity controlRelated but functionally distinct protein (e.g., PSAK)Non-specific effects
  • Statistical design considerations:

Statistical AspectRecommendationJustification
Biological replicatesMinimum n=3, preferably n≥5Account for biological variability
Technical replicatesMinimum 3 per biological replicateControl for measurement error
Statistical testsANOVA with post-hoc tests for multiple comparisonsCompare across multiple conditions
Power analysisPrior determination of sample size neededEnsure adequate statistical power
Effect size reportingCohen's d or similar metricsIndicate practical significance
  • Specific considerations for recombinant protein studies:

  • Batch-to-batch variability control (reference standards across experiments)

  • Expression level normalization (particularly for in vivo studies)

  • Tag interference assessment (comparison of different tag positions/types)

  • Post-translational modification verification

  • Protein stability validation across experimental conditions

Methodologically, researchers should implement systematic record-keeping of all experimental variables, blinded analysis when possible to reduce bias, and consistency checks between different experimental approaches.

How can researchers interpret contradictions between in vitro and in vivo results?

Contradictions between in vitro and in vivo findings are common in studies of photosynthetic proteins like PSAH. Resolving these discrepancies requires systematic analysis of potential contributing factors:

  • Common sources of contradictions:

Contradiction TypePotential CausesResolution Approaches
Binding affinity differencesMissing cofactors, detergent effectsReconstitution in nanodiscs/liposomes
Activity level disparitiesLack of regulatory PTMs, missing partnersPTM mimetics, co-expression systems
Localization inconsistenciesOverexpression artifacts, tag interferenceDose-dependent studies, alternative tagging
Phenotypic effectsCompensation mechanisms in vivoInducible/tissue-specific expression
  • Systematic reconciliation framework:

A hierarchical approach to resolving contradictions includes:

  • Technical validation: Verify protein integrity in both systems

  • Contextual analysis: Identify missing components in vitro

  • Integrative interpretation: Develop models that accommodate both observations

  • Case example: PSAH binding affinity discrepancy

ParameterIn Vitro ObservationIn Vivo ObservationReconciliation Approach
LHCII bindingWeak (Kd ≈ 5 μM)Strong (co-purifies readily)Test phosphorylation effects, add missing subunits
StabilityHalf-life of hoursHalf-life of daysExamine proteostasis factors, membrane composition
Activity contributionMinimal effect on electron transportSignificant impact on photosynthesisMeasure under fluctuating conditions, assess state transitions

Methodologically, researchers should design experiments that systematically bridge in vitro and in vivo conditions, implement reconstitution systems of increasing complexity, and use computational modeling to identify key parameters explaining differences .

What are the common purification challenges for recombinant PSAH?

Recombinant expression and purification of PSAH presents several challenges due to its membrane protein nature and complex folding requirements. Common problems and their solutions include:

  • Expression challenges:

ChallengeManifestationSolutionsSuccess Indicators
Toxicity to hostSlow growth, plasmid lossTightly regulated promoters, C41/C43 E. coli strainsStable growth curves
Inclusion body formationInsoluble protein fractionLower temperature (16-20°C), fusion partners (MBP, SUMO)Increased soluble fraction
Improper membrane insertionDegradation, aggregationSignal sequence optimization, specialized strainsMembrane fraction localization
Low expression levelPoor yieldCodon optimization, increased copy numberDetectable expression by Western blot
  • Purification challenges:

ChallengeManifestationSolutionsTechnical Parameters
Poor solubilizationLow recovery from membranesDetergent screening (DDM, LMNG, digitonin)1-2% detergent, 4°C, gentle agitation
Co-purifying contaminantsMultiple bandsTandem affinity tags, ion exchange chromatographySalt gradient 50-500 mM
Protein instabilityLoss of yield during purificationAddition of lipids, glycerol, reduced temperature10% glycerol, 0.1 mg/mL lipid
Tag interferencePoor activityCleavable tags, alternative tag positionsTEV or PreScission protease sites
  • Optimized workflow for challenging cases:

  • Membrane preparation protocol:

    • Gentle cell disruption (osmotic shock or French press)

    • Separation of membrane fractions by ultracentrifugation

    • Washing steps to remove peripheral proteins

  • Solubilization optimization:

    • Systematic detergent screening (type and concentration)

    • Addition of cholesterol hemisuccinate as stabilizer

    • Inclusion of specific lipids (SQDG, DGDG) from thylakoids

Methodologically, researchers should implement parallel expression trials in multiple systems, develop rapid small-scale screening methods for detergents and buffers, and establish robust quality control checkpoints throughout purification.

How can researchers assess if recombinant PSAH maintains native structure?

Assessing whether recombinant PSAH maintains its native structure requires a combination of biophysical, biochemical, and functional techniques:

  • Structural integrity assessment:

TechniqueInformation ProvidedSample RequirementsResolution
Circular Dichroism (CD)Secondary structure content0.1-1 mg/mL protein, detergent-compatibleLow (secondary structure elements)
Fluorescence SpectroscopyTertiary structure, tryptophan environment0.01-0.1 mg/mL proteinLow (global folding)
Limited ProteolysisDomain organization, flexible regions0.5-1 mg/mL proteinMedium (domain level)
SEC-MALSOligomeric state, homogeneity0.5-1 mg proteinMedium (quaternary structure)
  • Stability and quality assessment:

TechniqueParameter MeasuredAdvantageTechnical Considerations
Differential Scanning CalorimetryThermal stability (Tm)Direct measurement of unfoldingRequires 0.5-1 mg protein
Thermal Shift AssayThermal stability (Tm)High-throughput, low sample consumptionRequires fluorescent dye compatibility
Native Mass SpectrometryIntact mass, complex stoichiometryDetects post-translational modificationsRequires specialized instrumentation
  • Functional assessment:

Assay TypeFunctional ParameterDetection MethodControl Comparison
Binding AssaysInteraction with partners (PSAL, LHCII)MST, SPR, fluorescence anisotropyNative PSI complex
Reconstitution AssaysIntegration into PSI complexesBN-PAGE, activity measurementsIn vivo assembled PSI
Electron TransportSupport of electron flowSpectroscopic methods (P700 oxidation)Isolated thylakoids
  • Integrated analytical workflow:

A comprehensive assessment strategy should progress through these stages:

  • Initial quality control with SDS-PAGE and Western blotting

  • Biophysical characterization with CD spectroscopy and thermal stability assays

  • Functional validation through partner protein binding assays

  • Advanced structural characterization with techniques like hydrogen-deuterium exchange

Methodologically, researchers should establish quality benchmarks by comparison with native protein, implement multiple complementary techniques, and correlate structural parameters with functional readouts .

How can recombinant PSAH be used to study PSI electron transfer mechanisms?

Recombinant PSAH can serve as a valuable tool for investigating electron transfer mechanisms in PSI, particularly by enabling controlled modifications that affect electronic coupling and energy transfer:

  • Experimental approaches:

ApproachImplementationInformation GainedTechnical Considerations
Site-directed spin labelingIntroduction of spin labels at specific positionsDistance measurements, conformational changesRequires EPR spectroscopy
Electron transfer modulationMutation of residues near cofactorsEffects on electron transfer ratesRequires ultrafast spectroscopy
Reconstitution studiesIntegration of recombinant PSAH into PSI complexesFunctional contribution to electron flowRequires intact PSI core preparation
Redox potential modificationIntroduction of charged residuesEffects on energeticsRequires electrochemical measurements
  • Specific investigations using recombinant PSAH:

  • Proton motive force effects: Recombinant PSAH can be used to study how changes in the electric field across the thylakoid membrane (Δψ) affect PSI electron transfer and recombination rates. Research has shown that high Δψ can promote recombination through the P+Pheo− pathway, increasing the risk of photodamage .

  • State transition efficiency: By reconstituting systems with wild-type or modified PSAH, researchers can measure how structural changes affect the efficiency of electron flow during state transitions when LHCII associates with PSI.

  • Redox tuning: Specific amino acid substitutions in PSAH can alter the local electrostatic environment of PSI cofactors, providing insights into how protein environment tunes electron transfer rates.

  • Technical methodologies:

  • Ultrafast transient absorption spectroscopy to measure electron transfer kinetics

  • Electron paramagnetic resonance to measure distances between cofactors

  • Electrochromic shift measurements to determine electric field effects

  • Fluorescence lifetime measurements to assess energy transfer efficiency

The link between structural features of PSAH and electron transfer efficiency can be particularly important in understanding how photosynthetic organisms balance efficient light harvesting with photoprotection under varying environmental conditions .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.